Dr. Kutikov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Avenue
Fox Chase Cancer Center
Philadelphia, PA 19111Phone+1 215-728-6900Fax+1 215-214-1734
Summary
- Dr. Kutikov is a board certified, academic urologic surgical oncologist who treats tumors of the adrenal, kidney, prostate, bladder, ureter, testis, and other genitourinary organs using minimally invasive (robotic/laparoscopic) and traditional surgical techniques: https://www.foxchase.org/alexander-kutikov
Dr. Kutikov's current research interests include understanding renal / prostatic carcinogenesis, risk-stratification of surgical outcomes, and quantification of competing risks: https://www.ncbi.nlm.nih.gov/myncbi/browse/collection/48687313/?sort=date&direction=descending
Education & Training
- Fox Chase Cancer CenterFellowship, Urologic Surgical Oncology, 2008 - 2010
- University of Pennsylvania Health SystemChief Residency, Urology, 2007 - 2008
- University of Pennsylvania Health SystemResidency, Urology, 2004 - 2007
- University of Pennsylvania Health SystemInternship, Urology, 2003 - 2004
- Harvard Medical SchoolClass of 2003
- Emory UniversityBachelor of Science, Chemistry, Woodruff Scholar, Summa Cum Laude, 1995 - 1999
- Oxford UniversityEmory’s Oxford Scholar, 1997 - 1998
Certifications & Licensure
- NJ State Medical License 2009 - 2025
- PA State Medical License 2003 - 2024
- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Mid-Atlantic AUA Young Investigator Representative to the AUA’s Research Forum American Urological Association Meeting, Washington, DC, 2011
- American College of Surgeons Excellence in Research Award 96th Annual Clinical Congress, Surgical Forum, 2010
- Join now to see all
Clinical Trials
- Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder Start of enrollment: 2016 Nov 11
Publications & Presentations
PubMed
- 39 citationsCoexisting Hybrid Malignancy in a Solitary Sporadic Solid Benign Renal Mass: Implications for Treating Patients Following Renal BiopsySerge Ginzburg, Robert G. Uzzo, Tahseen Al-Saleem, Essel Dulaimi, John Walton
The Journal of Urology. 2014-02-01 - 53 citationsDefects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerBenjamin Miron, Jean H. Hoffman-Censits, Fern Anari, John O'Neill, Daniel M. Geynisman
European Urology Oncology. 2020-03-10 - 18 citationsPapillary Renal Neoplasm With Reverse Polarity Is Often Cystic: Report of 7 Cases and Review of 93 Cases in the Literature.Shuanzeng Wei, Alexander Kutikov, Arthur S. Patchefsky, Douglas B. Flieder, Jacqueline Talarchek
The American Journal of Surgical Pathology. 2021-08-05
Journal Articles
- Assessment of Volume Preservation Performed Before or After Partial Nephrectomy Accurately Predicts Postoperative Renal Function: Results from a Prospective Multicente...Alexander Kutikov, Robert G Uzzo, Brian R Lane, Urologic Oncology
- Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid FeaturesRichard E Greenberg, Rosalia Viterbo, Timothy Ito, Marc C Smaldone, Joseph R Testa, Philip H Abbosh, Robert G Uzzo, Alexander Kutikov, The Journal of Urology
- Testicular Compartment Syndrome: A New Approach to Conceptualizing and Managing Testicular Torsion.Kutikov A, Casale P, White MA, Mayer WA, Chang A, Gozalbez R, Canning DA., Urology
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- mTOR pathway activation in primary renal cell carcinoma and match metastases.Kutikov A, Egleston BL, Morrison T, Henske EP, Huang M, Al-Saleem T, Uzzo RG., American Urological Association Meeting, Chicago, IL
- Routine Adrenalectomy is Unnecessary During Surgery for Renal Cell Carcinoma – Event for Large and/or Upper Pole Tumors.Kutikov A, Piotrowski Z, Canter DJ, Kister DL, Litwin S, Chen DYT, Viterbo R, Greenberg RE, Boorjian SA, Uzzo RG., American Urological Association Meeting, San Fransisco, CA
- Anatomical Features of Enhancing Renal Masses Predict Histology and Grade – an Analysis Using Nephrometry.Kutikov A, Manley BJ, Canter DJ, Egleston BL, Kister DL, Chen DYT, Greenberg RE, Boorjian SA, Viterbo R, Uzzo RG., American Urological Association Meeting, San Francisco, CA
- Join now to see all
Lectures
- Management of Adrenal Incidentaloma in the Patient with Cancer.Temple University General Surgery Grand Rounds
- Moderator for Podium Session on Urologic Oncology.Mid-Atlantic New England AUA Sectional Meeting, Orlando, FL
- Adrenal Mass in the Cancer Patient.University of Pennsylvania Urology Grand Rounds
- Join now to see all
Press Mentions
- Anti-PD-1 in BCG-Unresponsive Papillary Bladder TumorsMay 22nd, 2023
- The Two-Pronged Future of Urologic Oncology TreatmentMay 16th, 2023
- Temple Health Launches New Fox Chase-Temple Urologic InstituteApril 27th, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: